Home » Topics » BioWorld Science

BioWorld Science
RSS

NRx partners with IIBR to develop and commercialize BriLife COVID vaccine

July 15, 2021

New G12C mutant GTPase KRAS inhibitors presented by Novartis

July 15, 2021

Merck & Co. discovers protein arginine N-methyltransferase 5 inhibitors

July 15, 2021

Mutant EGFR inhibitors identified at Roche

July 15, 2021

New carboxylic acids synthesized at Prometic Pharma SMT

July 15, 2021

Oral fadraciclib enters phase I/II study in advanced solid tumors

July 14, 2021

Valo submits CTA for first-in-human study of PeptiCRAd-1 in melanoma, TNBC and NSCLC

July 14, 2021

Oryzon cleared to begin phase IIb trial of vafidemstat in schizophrenia

July 14, 2021

TP-03 enhances the stimulating effect of hCG on testicular steroidogenesis

July 14, 2021

ENA studies INNA-051 nasal spray in phase I to boost innate immunity against respiratory viruses

July 14, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...